Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-05-22

FDA Approved: HEPZATO KIT — Supplemental Application (Delcath Systems, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Hepzato Kit, a melphalan hydrochloride lyophilized injection, used with hepatic perfusion to treat ocular melano…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HEPZATO KIT (melphalan hydrochloride injection, lyophilized, for solution)

Snippet

SUPPL AP for HEPZATO KIT (MELPHALAN HYDROCHLORIDE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION)